Results From Breast Cancer Pilot Study Presented By NovoCure

NovoCure has announced that it presented the results from a single-arm pilot trial evaluating the Novo-TTF, a non-invasive portable medical device, combined with neo-adjuvant chemotherapy for the treatment of patients with locally advanced breast cancer. Tumor volume shrank by 86-100 percent in the first four patients treated with the combined therapy, and one patient has experienced a complete response.

More: continued here

Filed under: Breast Cancer on April 17th, 2008